VET

UPCOMAgriculture

Thuốc thú y Trung ương Navetco Joint Stock Company

Original Name: Công ty Cổ phần Thuốc thú y Trung ương Navetco

Reference Price14.900 ₫

Interactive Stock Chart

Exchange Ticker: UPCOM:VET

Listing Information

Exchange MarketUPCOM

Live SectorChemicals

First Trading Date13/12/2017

First Close Price₫19,600

Capital Structure

Charter Capital160 Billion VND

Listed Shares16,000,000

Outstanding Shares16,000,000

Treasury Shares-

Professional Advisors & Auditors

Independent Auditing History

Fiscal Year	Auditing Organization
2025	Dịch vụ Tư vấn Tài chính Kế toán và Kiểm toán Phía Nam Co., Ltd.
2024	Kiểm toán DFK Vietnam Co., Ltd.
2023	Dịch vụ Tư vấn Tài chính Kế toán và Kiểm toán Phía Nam Co., Ltd.
2022	Dịch vụ Tư vấn Tài chính Kế toán và Kiểm toán Phía Nam Co., Ltd.
2021	Kiểm toán DFK Vietnam Co., Ltd.
2020	Dịch vụ Tư vấn Tài chính Kế toán và Kiểm toán Phía Nam Co., Ltd.
2019	Dịch vụ Tư vấn Tài chính Kế toán và Kiểm toán Phía Nam Co., Ltd.
2018	Dịch vụ Tư vấn Tài chính Kế toán và Kiểm toán Phía Nam Co., Ltd.

IPO & Listing Consultant

Securities Ngân hàng Công thương Vietnam JSCListing Ticker Symbol: Công ty Cổ phần Chứng khoán Ngân hàng Công thương Việt Nam

Detailed Corporate Timeline & Sectors

Timeline of Establishment & Development:

Navetco Central Veterinary Medicine Joint Stock Company, formerly known as the National Institute of Microbiology and Cattle Pathology, was established in 1955 with the main function of diagnosing diseases and producing a small amount of vaccines for livestock.
Going through the process of operation, changing its name and merging with the Animal Husbandry and Veterinary Supplies Station into the Central Veterinary Medicine and Veterinary Supplies Company 2, the English name is National Veterinary Company (abbreviated as NAVETCO), in 2004, the Central Veterinary Medicine One Member Company Limited was officially established, based on available facilities, continued to operate and invest in upgrading techniques and production capacity to produce vaccines, pharmaceutical products in quantities that meet the needs of farmers.
On January 17, 2012, the Minister of Agriculture and Rural Development issued Decision No. 113/QD-BNN-DMDN on equitizing Central Veterinary Medicine One Member Company Limited.
On October 15, 2012, the Minister of Agriculture and Rural Development issued Decision No. 2511/QD-BNN-DMDN on approving the enterprise value of Central Veterinary Medicine One Member Company Limited for equitization.
On November 14, 2012, the Minister of Agriculture and Rural Development issued Decision No. 2899/QD-BNN-DMDN on approving the Equitization Plan and converting the Central Veterinary Medicine One Member LLC into a joint stock company.
On January 30, 2013, Ho Chi Minh City Stock Exchange organized the initial public auction of shares of Central Veterinary Medicine Company Limited.
On November 5, 2013, Navetco Central Aquatic Medicine Joint Stock Company was granted a Business Registration Certificate by the Department of Planning and Investment of Ho Chi Minh City (3rd change), the Company officially operates under the model of a joint stock company with a charter capital of 160,000,000,000 VND.
On May 17, 2017, the Company was granted securities registration certificate No. 100/2017/GCNCP-VSD by the Vietnam Stock Exchange with the registered quantity of 16,000,000 shares.

Business Sectors:

Production of veterinary drugs, aquatic veterinary medicine, biological products, chemicals used in aquatic veterinary medicine;
Trading in veterinary medicine, aquatic veterinary medicine, biological products, chemicals in veterinary medicine and aquatic veterinary medicine; Purchasing and selling raw materials, supplies, and equipment for the production of veterinary medicine and aquatic veterinary medicine;
Production of animal feed, poultry and aquatic products (except production and processing of fresh food, recycling of waste at headquarters);
Real estate business, land use rights belonging to owners, users or renters;
Scientific research on veterinary medicine, methods of diagnosis and disease prevention for livestock and poultry (except veterinary activities);
National reserve of veterinary medicine and aquatic veterinary medicine.

Address: 9 - 11 Ton Duc Thang, Ben Nghe Ward, District 1, Ho Chi Minh City

Phone: (028) 3822 5063 Fax: (028) 3822 5060

Disclosure Officer:

Email: [email protected]

Website: http://www.navetco.com.vn/

Ratio / Financial Indicator	2022	2023	2024	2025
Earnings Per Share (EPS)	₫3,319	₫1,786	-₫2,475	₫1,139
Price-to-Earnings (P/E)	4.49x	8.34x	-	13.08x
Book Value Per Share (BVPS)	₫21,305	₫21,288	₫18,771	₫19,910
Price-to-Book (P/B)	0.70x	0.70x	0.79x	0.75x
Return on Equity (ROE)	15.58%	8.39%	-13.18%	5.72%
Return on Assets (ROA)	5.98%	3.18%	-4.76%	2.33%
Net Profit Margin	11.53%	6.93%	-10.67%	5.96%
Debt-to-Equity Ratio	1.60	1.64	1.77	1.45
Current Ratio	1.43	1.53	1.54	1.89

Audited Financial Statements

Source: KB Securities (KBS) Datafeed • Updated dynamically

Show absolute values (VND)

Doanh thu thuần về bán hàng và cung cấp dịch vụNet revenue

-33.7% YoY

Lợi nhuận sau thuế thu nhập doanh nghiệpNet profit after tax

-65.7% YoY

TỔNG CỘNG TÀI SẢNTOTAL ASSETS

-12.0% YoY

Financial Indicator (VND)	2025	2024	2023	2022
1. Doanh thu bán hàng và cung cấp dịch vụ 1. Revenue	307,136,284,000	371,268,763,000	412,646,744,000	460,764,232,000
2. Các khoản giảm trừ doanh thu2. Deduction from revenue	1,473,113,000	-	-	79,760,000
3. Doanh thu thuần về bán hàng và cung cấp dịch vụ3. Net revenue	305,663,171,000	371,268,763,000	412,646,744,000	460,684,472,000
4. Giá vốn hàng bán 4. Cost of goods sold	183,255,419,000	206,637,210,000	232,730,976,000	255,963,710,000
5. Lợi nhuận gộp về bán hàng và cung cấp dịch vụ5. Gross profit	122,407,752,000	164,631,553,000	179,915,768,000	204,720,761,000
6. Lãi/Lỗ của hoạt động bán, thanh lý bất động sản đầu tư6. Gain/(Loss) on disposal of investment property	-	-	-	-
7. Doanh thu hoạt động tài chính 7. Financial income	7,919,000	99,380,000	1,234,835,000	2,326,286,000
8. Chi phí tài chính 8. Financial expenses	13,131,015,000	8,874,416,000	8,691,148,000	4,213,993,000
Trong đó: Chi phí đi vay Of which: Interest expense	7,128,513,000	3,989,393,000	2,822,842,000	72,608,000
8. Phần lãi/lỗ trong công ty liên doanh, liên kết8. Share of associates and joint ventures' result	-	-	-	-
9. Chi phí bán hàng 9. Selling expenses	46,308,507,000	105,310,524,000	77,641,093,000	74,963,421,000
10. Chi phí quản lý doanh nghiệp 10. General and administrative expenses	56,651,661,000	53,549,821,000	60,105,235,000	68,991,781,000
11. Lợi nhuận thuần từ hoạt động kinh doanh11. Operating profit	6,324,488,000	-3,003,829,000	34,713,127,000	58,877,852,000
12. Thu nhập khác 12. Other income	18,660,117,000	13,704,610,000	2,699,733,000	8,789,587,000
13. Chi phí khác 13. Other expenses	6,759,522,000	50,297,145,000	1,220,052,000	1,025,581,000
14. Lợi nhuận khác14. Other profit	11,900,595,000	-36,592,535,000	1,479,682,000	7,764,006,000
Phần lợi nhuận/lỗ từ công ty liên kết liên doanhShare of associates and joint ventures' result	-	-	-	-
15. Tổng lợi nhuận kế toán trước thuế15. Profit before tax	18,225,083,000	-39,596,364,000	36,192,808,000	66,641,858,000
16. Chi phí thuế TNDN hiện hành16. Current corporate income tax expenses	-	-	7,610,328,000	13,533,488,000
17. Chi phí thuế TNDN hoãn lại 17. Deferred income tax expenses (*)	-	-	-	-
18. Lợi nhuận sau thuế thu nhập doanh nghiệp18. Net profit after tax	18,225,083,000	-39,596,364,000	28,582,481,000	53,108,370,000
Lợi ích của cổ đông thiểu sốMinority Interest	-	-	-	-
Lợi nhuận sau thuế của cổ đông của Công ty mẹProfit after tax for shareholders of parent company	18,225,083,000	-39,596,364,000	28,582,481,000	53,108,370,000
19. Lãi cơ bản trên cổ phiếu (VNÐ)19. Earnings per share (VND)	1,139	-2,475	1,545	2,538
20. Lãi suy giảm trên cổ phiếu (*)20. Diluted earnings per share	1,000	-2,000	-	-

Data Source & Disclaimer

Data Source: Financial statement data is automatically aggregated from official disclosure feeds of listed companies through the analysis system of KB Securities Vietnam JSC (KB Securities).

Disclaimer: All financial data displayed on this website is provided for general reference purposes only. We make every effort to update accurate data but do not provide any warranty regarding its completeness or absolute reliability. The displayed figures do not constitute investment advice or an offer to trade securities. Users assume all risks and responsibilities for any financial decisions made based on the data on this website.

VET

Thuốc thú y Trung ương Navetco Joint Stock Company

Interactive Stock Chart

Listing Information

Capital Structure

Professional Advisors & Auditors

Independent Auditing History

IPO & Listing Consultant

Detailed Corporate Timeline & Sectors

Key Financial Ratios (2025)

Historical Financial Metrics (YoY)

Financial Ratios Reference & Interpretation Guide

Audited Financial Statements

VET — Financial Data Summary (2022–2025)

Executive Summary

Operating Performance & Profitability

Asset Structure & Financial Leverage

Cash Flow Quality